Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow

Leukemia

Volumn 11, Issue 10, 1997, Pages 1650-1653

  Taylor, P R A ^a   Jackson, G H ^a   Lennard, A L ^a   Hamilton, P J ^a   Proctor, S J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Autologous transplant; Non cryopreserved marrow; Secondary malignancy

Indexed keywords

ANTINEOPLASTIC ALKALOID; CHLORMETHINE DERIVATIVE; ETOPOSIDE; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; FEMALE; HODGKIN DISEASE; HUMAN; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; TRISOMY;

EID: 0030710238     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400795     Document Type: Article

References (22)

1. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure (review). Sem Oncol 1992; 19: 47-84.
2. Pedersen-Bjergaard J, Hansen SW, Larsen SO, Daugaard G, Philip P, Rorth M. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991; 338: 359-363.
3. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G. Second acute leukaemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986; 4: 830-837.
4. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT. Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med 1996; 334; 745-751.
5. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
6. Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rainowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2535-2542.
7. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies, J Clin Oncol 1994; 12: 2527-2534.
8. Milligan DW, Kolb HJ, Pearce R, Taghipour G, Goldstone AH, for the Lymphoma and Late Effects Working Parties. MDS after autografting for lymphoma: a retrospective analysis of the EBMT Registry. Bone Marrow Transplant 1996; 17: 468 (Abstr.).
9. Marolleau JP, Brice P, Morel P, Gisselbrecht C. Secondary acute myeloid leukaemia after autologous bone marrow transplantation for malignant lymphoma. J Clin Oncol 1993; 11:590-591 (Abstr.).
10. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 1994; 84: 957-963.
11. Bierman PJ, Bagin RG, Jagannath S, Vose JM, Spitzer G, Kessinger A, Dicke KA, Armitage JO. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients. Ann Oncol 1993; 4: 767-773.
12. Rohatiner AZS, Johnson PWM, Price CGA, Arnott SJ, Amess JAL, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J, MacCallum PK, Oza AM, Lister TA. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177-1184.
13. Andre M, Henry-Amar M, Colombat P, Fleury J, Milpied N, Bastion Y, Cahn JY, Nedellec G, Tilly R, Pico JL, Blaise D, Attal M, Muentz M, Biron P, Jouet JP, Ferme C, Gisselbrecht G, for the SFGM HS, Paris. Autologous stem cell transplantation (ASCT) for Hodgkin's disease (HD): incidence of second cancers (SC) and causes of death. Ann Oncol 1996; 7: 18 (Abstr.).
14. Taylor P, Jackson GH, Lennard A, Hamilton PJ, Proctor SJ. Low frequency of myelodysplasia after autologous bone marrow transplantation. Lancet 1995; 345: 1248-1249 (Abstr.).
15. Taylor PRA, Jackson GH, Lennard AL, Lucraft H, Proctor SJ, on behalf of the Newcastle and Northern Region Lymphoma Group. Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. Br J Cancer 1993; 67: 383-387.
16. Jackson GH, Lennard AL, Taylor PRA, Carey P, Angus B, Lucraft H, Evans RGB, Proctor SJ, on behalf of the Newcastle and Northern Lymphoma Group. Autologous bone marrow transplantation in poor risk high grade non-Hodgkin's lymphoma in first complete remission. Br J Cancer 1994; 70: 501-505.
17. Hayward RL, Leonard RCF, Prescott RJ, Allan NC, Das SN, Dawson AA, Heppleston A, Lessells AM, Lucraft HH, Mackie MJ, MacGillivray JB, MacLaren KS, Parker AC, Proctor SJ, Ritchie GL, Sarkar TK, White JM, A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Br J Cancer 1991; 63: 945-952.
18. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med 1993; 329: 987-994.
19. Jackson GH, Taylor PRA, Carey PJ, Goff DK, Finney RD, Galloway MJ, Proctor SJ. Ifosphamide, VP16 and epirubicin (IVE) in the treatment of Hodgkin's disease: a report on toxicity and efficacy. Br J Haematol 1995; 89: 76 (Abstr.).
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Jackson GH, Latham J, Lennard A, Taylor P, Proctor SJ. Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease. Br J Haematol 1994; 87: 193-195.
22. Dady PJ, McElwain TJ, Austin DE, Barrett A, Peckham MJ. Five years experience with ChlVPP: effective low toxicity combination chemotherapy for Hodgkin's disease. Br J Cancer 1982; 45: 851-859.